HOME >> MEDICINE >> NEWS
Zengen's new study reviews novel approach to control inflammation using melanocortin receptors

WOODLAND HILLS, Calif. (March 3, 2004) Zengen, Inc. announced today that its researchers have discovered that activation of melanocortin receptors (MCR) subtypes MC1R and MC3R could be a novel strategy to control inflammatory disorders.

The findings, "Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation," appear in the March 2004 issue of Pharmacological Reviews, a publication of the American Society for Pharmacology and Experimental Therapeutics (ASPET).

"MCR activation causes a collective reduction of the major molecules involved in the inflammatory process," said Anna Catania, M.D., professor of endocrinology, School of Internal Medicine, University of Milan and lead author of the study. "This discovery is significant because it shows that treatment with melanocortin peptides doesn't abolish the inflammatory response but instead modulates it. An advantage of melanocortins in the treatment of inflammation is that their influences are broad and are not restricted to a specific mediator or chemical pathway."

Recognition and cloning of five melanocortin receptors has greatly improved understanding of peptide-target cell interactions. Preclinical investigations indicate that activation of certain MCR subtypes, primarily MC1R and MC3R, could be useful in treatment of localized and systemic inflammatory disorders. These include: organ transplantation, chronic inflammatory diseases, acute inflammation, inflammation within the brain and neurogenerative disorders, peripheral neuropathies, systemic host reactions, ischemia and reperfusion injury and infections.

"The study results also indicate that certain melanocortin peptides have antimicrobial effects," said James Lipton, Ph.D., chief scientific officer and director of Zengen and study author. "Unlike corticosteroids, melanocortins do not reduce microbial killing activity, but enhance it. We are encouraged by these findings and will continue our res
'"/>


3-Mar-2004


Page: 1 2

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. UMaine study looks at infants and chronic nighttime crying
3. Chronic pain treatments more effective when taken together, new study shows
4. UNC study: Most N.C. family practitioners engage in unrecognized community service
5. New study in Nature demonstrates protection against cell death during heart attack
6. UCSF study offers insight into human circadian rhythms
7. International breast cancer prevention study launches in the United States and Canada
8. UW study shows blacks and Latinos are more satisfied with physicians of the same race
9. Physicians may not be accurate in their confidence levels of their diagnoses, says Pitt study
10. Advertising by academic medical centers may risk eroding public trust, says study
11. Fat may promote inflammation, new study suggests

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2020)... ... February 11, 2020 , ... R3 Medical Training is now ... 2020 in Las Vegas. The training consists of thread lift placement on real patients ... , PDO thread lifts represent an excellent alternative currently for nonoperative facelift. The procedures ...
(Date:2/10/2020)... , ... February 10, 2020 , ... ... Health and Epidemiology Practice, has been elected president of the Society for ... she and her team develop and implement award-winning, research-driven Federal social marketing campaigns ...
(Date:2/10/2020)... SANTA BARBARA, Calif. (PRWEB) , ... ... ... Palette Life Sciences, Inc., a medical device company dedicated to assisting ... conditions and diseases, today announced the launch of the Solesta® Reimbursement Assistance ...
(Date:2/10/2020)... ... February 10, 2020 , ... American Family Care (AFC), ... aggressively expanding its healthcare network across New England. The first phase includes ... the fast-growing healthcare system. , AFC’s Founder and CEO, Dr. Bruce Irwin , ...
(Date:2/9/2020)... ... 09, 2020 , ... Kim A. Gorgens, Ph.D., ABPP is ... University of Denver. Since 2013, Dr. Gorgens and The Brain Injury Alliance of ... determined that 50-80% of the inmates in Denver County Jails have traumatic brain ...
Breaking Medicine News(10 mins):
(Date:2/10/2020)... (PRWEB) , ... February 10, 2020 , ... A device ... called Hush Buddy -- a patented sleep training system for children, launching today ... their parents. , With the Hush Buddy Sleep System, getting a child to sleep ...
(Date:2/10/2020)... (PRWEB) , ... February 10, 2020 , ... ... healthcare industry from cyberattacks. One way Alpine is securing healthcare is by working ... Medical devices range from external systems, such as drug infusion pumps or patient ...
(Date:2/7/2020)... ... February 07, 2020 , ... Isagenix International ... announced the grand prize winner of its 2020 U.S. IsaBody Challenge® at the ... Washington, was honored onstage in front of thousands of Isagenix independent distributors and ...
Breaking Medicine Technology:
Cached News: